Crossmark

Precision medicine in sepsis: lessons from the TIGRIS trial and the reawakening of targeted therapy

Crossref DOI link: https://doi.org/10.1186/s44158-026-00393-9

Published Online: 2026-05-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iba, Toshiaki https://orcid.org/0000-0002-0255-4088
Helms, Julie https://orcid.org/0000-0003-0895-6800
Okada, Hideshi

Nagakari, Kunihiko https://orcid.org/0009-0002-4141-9062
Ferrer, Ricard https://orcid.org/0000-0002-4859-4747
License Information

Text and Data Mining valid from 2026-05-04

Version of Record valid from 2026-06-22
More Information

Article History

Received: 28 January 2026

Accepted: 21 April 2026

First Online: 4 May 2026

Declarations

:

: The authors declare no competing interests.